Inhibitors of angiogenesis, compositions containing same and use thereof for the treatment of diseases associated with deregulation of angiogenesis
FR2865735A1
Inhibitors of angiogenesis, compositions containing same and use thereof for the treatment of diseases associated with deregulation of angiogenesis
FR2864082A1
New morphine-6-glucuronide derivative, pharmaceutical composition containing same and use thereof for the treatment of pain
FR2851471A1
Compounds comprising at least one active substance and at least one vector connected by a binding agent, uses thereof and the binding agents
FR2840810A1
Composition for the transfer of therapeutic molecules to lungs and their use in the treatment of lung cancers and pulmonary diseases
FR2836474A1
Compounds, compositions and method for transporting cyclosporin molecules through the hematoencephalic barrier
FR2834465A1
Compositions for the vectorization of oligonucleotides through the hematoencephalic barrier and their use for the treatment of diseases of the central nervous system
FR2829940A1
New composition, useful for treating central nervous system diseases, comprises an antibody linked to a linear peptide and is able to cross the blood-brain barrier
FR2830016A1
Compositions for the vectorization of taxoid derivatives through the hematoencephalic barrier and their use for the treatment of cancers, particularly brain cancers
FR2821272A1
Compounds consisting of an analgesic molecule linked to a vector capable of vectorizing the same moleculated through the hematoencephalic barrier and pharmaceutical compositions containing them
FR2818981A1
Amphipathic peptides and their use for the transfer of substances of interest to cells
FR2810985A1
Amphipathic linear peptides and compositions containing them
FR2786398A1
Anti-cancer and anti-chemoresistance pharmaceutical composition comprising an anti-cancer agent and at least one peptide
FR2786397A1
Peptide vectors of substances through the hematoencephalic barrier for use in diagnosis or therapy of cns disease
FR2773240A1
Process for predicting, identifying and describing molecules likely to present research behavior, especially in the field of pharmacy and molecules obtained by this process
FR2767323A1
Linear peptides derived from antibiotic peptides, their preparation and their use for vectorizing active substances
